Ecomed Solutions announced that its HEMAsavR has received an Innovative Technology contract from Vizient, Inc. The contract was based on a recommendation of HEMAsavR by hospital experts in this category who serve on one of Vizient’s member-led councils. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
HEMAsavR provides a new option for blood management teams to collect and transfer a patient’s own blood during and after surgical procedures helping health systems to reduce costly and complex donor blood transfusions.
David Yurek, CEO of Ecomed Solutions said, “Never has a blood capture and transfer device been so easy to use. I’m confident that HEMAsavR will bring significant value to healthcare systems interested in reducing dependency on donor blood. It’s a win-win proposition for both the patient and hospital.”
The HEMAsavR is a unique sterile collection and transfer device that does not require specialized resources for collection. This allows clinicians to economically collect more viable, sterile, anti-coagulated blood for evaluation for cell salvage processing and return to the patient, resulting in improved health outcomes.
“Hospitals and providers are looking for innovations that offer unique and cumulative benefit over other products available on the market today. Our member council determined this technology met the criteria to be recognized with the Innovative Technology designation. Congratulations to Ecomed Solutions on receiving this status,” said Debbie Archer, director of procurement and Vizient Innovative Technology Program leader.
